AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma
January 11, 2018Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma
AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …
AIDS charity lambasts “ethically challenged” Gilead over price hikes
January 11, 2018Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …
Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid
January 11, 2018Sales and Marketing Merck KGaA, nestle, pharma
It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …
NHS no longer able to deliver on standards, warn bosses
January 11, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The struggles of the NHS this winter are no secret, especially after being front and centre of the first Prime …
Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations
January 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …
Lundbeck partners with Vanderbilt University on schizophrenia research project
January 10, 2018Research and Development
Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to develop a …
New project examining FDA-approved drugs for Alzheimer’s, worries over research remains
January 10, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …
Bayer and J&J successfully reverse $28 million Xarelto court payout
January 10, 2018Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma
Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …
Slow-release, once-weekly pill for HIV developed
January 10, 2018Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical
Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …
Swallowable capsules could revolutionise bowel disorder treatment
January 9, 2018Research and Development biotech, drugs, pharma, pharmaceutical
Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening …
Sri Lanka to build first-ever pharmaceutical manufacturing zone
January 9, 2018Manufacturing and Production Pharma Zone, Sri Lanka, manufacturing, pharma
Sri Lanka is set to build its first-ever exclusive pharmaceutical manufacturing zone, it has emerged. The State Pharmaceuticals Manufacturing Corporation …
Six-strong collaboration to sequence 500,000 exomes
January 9, 2018Manufacturing and Production, Research and Development UK Biobank, biotech, drugs, pharma, pharmaceutical
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of …
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Hunt resists move from health secretary position, receives expanded role
January 9, 2018Manufacturing and Production, Medical Communications Jeremy Hunt, NHS, Theresa May, biotech, drugs, pharma, pharmaceutical
As part of Theresa May’s well-publicised cabinet reshuffle, many were expecting Jeremy Hunt to move from his position as Secretary …
Ex-Genentech exec named as new Juno Therapeutics CIO
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics
Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
Sanofi and Alynylam rejig sees global rights switch-up
January 8, 2018Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
The PROs and cons of pushing patient centricity
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma
As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
FDA clears Amgen’s bone drug for multiple myeloma
January 8, 2018Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma
Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
Celgene in $7bn shot on Impact
January 8, 2018Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical
Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
